AGXT Antikörper (AA 330-392)
Kurzübersicht für AGXT Antikörper (AA 330-392) (ABIN7596083)
Target
Alle AGXT Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 330-392
-
Verwendungszweck
- Human AGXT antibody
-
Aufreinigung
- Purified
-
Immunogen
- Recombinant AGXT (330-392aa) purified from E. coli
-
Isotyp
- IgG2b kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing cycles
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- AGXT (Alanine Glyoxylate Aminotransferase (AGXT))
-
Andere Bezeichnung
- AGXT
-
Hintergrund
- The AGXT gene provides instructions for making a liver enzyme called alanine-glyoxylate aminotransferase.Inside liver cells, this enzyme is found in peroxisomes, structures that contain many different enzymes used toproduce energy and the basic materials important for cellular activities. AGXT converts a compound calledglyoxylate to glycine, an amino acid that is a building block for making enzymes and other proteins.
-
NCBI Accession
- NP_000021
-
Pathways
- Monocarboxylic Acid Catabolic Process, Dicarboxylic Acid Transport
Target
-